The global epistaxis market is expected to grow at a significant CAGR during the forecast period. epistaxis is a condition that causes sporadic nose bleeding in one or both nostrils. Depending on where the bleeding begins, this clinical condition is defined as anterior epistaxis or posterior epistaxis. Nearly 10% of nosebleeds are life-threatening, and epistaxis is responsible for 4 out of every 2.4 million mortalities. This disease affects both young children with age 2-10 years and older persons with age between 50-80 years, however, it affects those over 50 years of age more frequently. Males have a higher prevalence (58%) than females (42%).
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/epistaxis-market
Epistaxis usually responds well to nasal cauterization, nasal packing, or a combination of the two treatments. Surgical alternatives or embolization procedures are frequently indicated for people who have recurrent nosebleeds. These procedures are accessible in hospitals and ENT clinics. Cauterization is a process that involves removing or burning a small piece of tissue near the bleeding site using chemicals such as silver nitrate or mild electric shocks.
Further, local trauma, such as sinus infection or even nose picking, is the most common cause of epistaxis and is more common in people who use anticoagulant drugs such as warfarin, clopidogrel, aspirin, or any other anticoagulant. Furthermore, there are a variety of topical applications on the market, such as tranexamic acid, that allows to stop nosebleeds. Therefore, the increase in the number of incidences of nosebleeds is contributing to the growth of the global epistaxis market.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Smith & Nephew plc, and King Pharmaceuticals, Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Epistaxis Market by Segment
By Indication
- Anterior Epistaxis
- Posterior Epistaxis
By Product Type
- Vasoconstrictors
- Anesthetics
- Antibiotic Ointments
- Cauterizing Agents
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
A full report of Epistaxis Market is available at: https://www.omrglobal.com/industry-reports/epistaxis-market
Epistaxis Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Smith & Nephew plc
- King Pharmaceuticals, Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
